Lori Lennon is the founder and CEO of Thinkubator Media, a science communications and media company that supports innovators and their ideas.
In this role, Lori works closely with companies and corporations incubating new subsidiaries, especially those preparing to enter the U.S. market. Her global-facing approach helps teams translate technical value for non-technical stakeholders and build plain-language narratives that travel across geographies and cultures. She also partners with incubators and accelerators to prepare founders and program leads for high-stakes moments and convert momentum into measurable traction.
Lori works extensively with tech transfer offices in academia and industry to clarify value propositions, prepare investigators and licensing teams for partner conversations, and turn complex science into credible, fundable stories.
She also founded the Women in STEM program, crafted directly from industry feedback to build practical visibility and funder-ready storytelling.
As CEO, Lori has been featured as a commentator on television news stations, moderated panels at global biotech conferences, and coordinated briefings and community events with elected officials. She is also the recipient of the 2025 Women Who Empower Innovator Award from Northeastern University.
Before launching Thinkubator Media, Lori served as director of communications for Northeastern University’s College of Science, collaborating with researchers tackling climate change, renewable energy, and drug discovery. She contributed to university communications groups, served on the College of Science Diversity and Inclusion Committee, and advised the student-run magazine NUSCI.
Earlier in her career, Lori worked in television news at New England Cable News and WBZ-TV Boston during a formative period for digital journalism, helping pioneer web coverage and interactive formats. During her tenure, WBZ.com earned several awards, including the Edward R. Murrow Award and recognition from the Associated Press.
Lori and the Thinkubator Media team have worked with organizations such as Novartis Institutes for Biomedical Research, Eli Lilly, Harvard University, Northeastern University, the Whitehead Institute, Washington University in St. Louis, and the National Institutes of Health.
